Global Ethyl (SChlorHydroxybutyrate (CAS 867280) Market by Type, Purity, Application and Region - Global Industry Analysis, Size, Share, Growth Trends and Forecast to 2030.
The global ethyl (schlorhydroxybutyrate) market is expected to reach USD 1.5 billion by 2030 from USD 0.8 billion in 2018 at a CAGR of 10.2% during the forecast period from 2021-2030. The growth of the market is attributed to increasing demand for ethyl (schlorhydroxybutyrate) as an active pharmaceutical ingredient in the treatment of various diseases such as diabetes mellitus type 2 and obesity among others. Moreover, increasing awareness about its benefits among patients is also driving the growth of this market globally. However, high cost associated with its production may hamper the growth of this market during the forecast period from 2021-2030.
The global ethyl (schlorhydroxybutyrate) market has been segmented on basis of type into purity 9899%, purity above 99%, application into atorvastatin calcium medicines and region into North America, Latin America Europe Asia Pacific Middle East & Africa regions respectively.
Some Of The Growth Factors Of This Market:
- Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) is a chemical compound that is used as an intermediate in the production of other chemicals.
- Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) has been found to be effective in treating certain types of cancer, such as leukemia and lymphoma, and it can also be used to treat some forms of epilepsy.
- Ethyl (S)-4-Chloro-3 -Hydroxybutyrate (CAS 86728 85 0) is a colorless liquid with a sweet odor that can be synthesized from acetone and chloral hydrate or from ethylene oxide and hydrochloric acid.
- The major players in the global market for Ethyl(s)- 4 Chloro 3 Hydroxybutyrate(cas 86728 85 0) are Dow Chemical Company, BASF SE, Eastman Chemical Company.
Industry Growth Insights published a new data on “Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market”. The research report is titled “Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market research by Types (Purity: 98%-99%, Purity Above 99%, ), By Applications (Atorvastatin Calcium, Other Medicines, ), By Players/Companies Jiangxi Aifeimu Technology, Zhangjiagang Jinuo Chemical, Pingxiang Pharmacon Technology, Nantong Nuosen, Further Pharmaceutical, Yancheng Huahong Chem, Enzy Tech”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Research Report
By Type
Purity: 98%-99%, Purity Above 99%,
By Application
Atorvastatin Calcium, Other Medicines,
By Companies
Jiangxi Aifeimu Technology, Zhangjiagang Jinuo Chemical, Pingxiang Pharmacon Technology, Nantong Nuosen, Further Pharmaceutical, Yancheng Huahong Chem, Enzy Tech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Industry Outlook.svg)
Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Report Segments:
The global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) market is segmented on the basis of:
Types
Purity: 98%-99%, Purity Above 99%,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Atorvastatin Calcium, Other Medicines,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jiangxi Aifeimu Technology
- Zhangjiagang Jinuo Chemical
- Pingxiang Pharmacon Technology
- Nantong Nuosen
- Further Pharmaceutical
- Yancheng Huahong Chem
- Enzy Tech
-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Overview.svg)
Highlights of The Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity: 98%-99%
- Purity Above 99%
- By Application:
- Atorvastatin Calcium
- Other Medicines
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ethyl (S)-4-chloro-3-hydroxybutyrate is a chemical compound with the molecular formula C5H10O2. It is a white solid that is soluble in water and most organic solvents. Ethyl (S)-4-chloro-3-hydroxybutyrate has been used as an intermediate in the production of other chemicals, including butanol and chlorobutanol.
Some of the major companies in the ethyl (s)-4-chloro-3-hydroxybutyrate (cas 86728-85-0) market are Jiangxi Aifeimu Technology, Zhangjiagang Jinuo Chemical, Pingxiang Pharmacon Technology, Nantong Nuosen, Further Pharmaceutical, Yancheng Huahong Chem, Enzy Tech.
The ethyl (s)-4-chloro-3-hydroxybutyrate (cas 86728-85-0) market is expected to register a CAGR of 10.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market - Supply Chain
4.5. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Forecast
4.5.1. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Absolute $ Opportunity
5. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Type
5.3.1. Purity: 98%-99%
5.3.2. Purity>99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
6.3.1. Atorvastatin Calcium
6.3.2. Other Medicines
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share Forecast, 2019-2026
9. North America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
9.4.1. Atorvastatin Calcium
9.4.2. Other Medicines
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Type
9.7.1. Purity: 98%-99%
9.7.2. Purity>99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share Forecast, 2019-2026
10. Latin America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
10.4.1. Atorvastatin Calcium
10.4.2. Other Medicines
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Type
10.7.1. Purity: 98%-99%
10.7.2. Purity>99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share Forecast, 2019-2026
11. Europe Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
11.4.1. Atorvastatin Calcium
11.4.2. Other Medicines
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ethyl (S)-4-Chloro-3-Hydroxybutyate (CAS 86728-85-0) Market Size and Volume Forecast by Type
11.7.1. Purity: 98%-99%
11.7.2. Purity>99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share, 2019-2026
12. Asia Pacific Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
12.4.1. Atorvastatin Calcium
12.4.2. Other Medicines
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Type
12.7.1. Purity: 98%-99%
12.7.2. Purity>99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share, 2019-2026
13. Middle East & Africa Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Application
13.4.1. Atorvastatin Calcium
13.4.2. Other Medicines
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market Size and Volume Forecast by Type
13.7.1. Purity: 98%-99%
13.7.2. Purity>99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market: Market Share Analysis
14.2. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Distributors and Customers
14.3. Ethyl (S)-4-Chloro-3-Hydroxybutyrate (CAS 86728-85-0) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Jiangxi Aifeimu Technology
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhangjiagang Jinuo Chemical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pingxiang Pharmacon Technology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nantong Nuosen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Further Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Yancheng Huahong Chem
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Enzy Tech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
